Red Thread’s Ariadne Software moves under BioData Solutions’ parent umbrella
Lawrence, KS; April 1, 2023: On April 1, 2023, Ariadne Software® officially became part of its parent company, BioData Solutions®, LLC. Originally founded by Dr. Stephanie Pasas-Farmer in 2015, BioData Solutions is a bioanalytical scientific advisory firm that helps pharmaceutical, contract research and biotechnology organizations to advance early-stage molecules into potential new drug candidates; BioData Solutions provides consulting and support for bioanalysis, regulatory compliance planning, and numerous other offerings.
Ariadne Software, which was also founded by Dr. Pasas-Farmer, is a pharmaceutical software solutions company best known for a first-of-its-kind, AI-driven solution called Red Thread®. Red Thread automates specific preclinical and clinical bioanalytical processes; this automation, in turn, reduces time and costs for those trials, boosts consistency in approach and results, and improves resource management and transparency between sponsors and CROs.
Although founded three years apart, BioData Solutions and Ariadne often serve the same clientele and provide offerings in the same drug development function. With these two entities combined, previously separate teams now collaborate; data analysis and auditing are now streamlined; and both BioData Solutions and Ariadne Software are empowered to deliver a faster, more seamless experience for all clients.
“We’re extremely excited about this new joint effort,” states Dr. Pasas-Farmer, President of both companies. “The strategy-to-tactics consulting capabilities that BioData Solutions provides for bioanalytical assays, combined with Ariadne’s AI-driven solutions that accelerate analysis and auditing of these assays, will give sponsors, CROs and other bioanalysis teams a definitive edge. The improved data accuracy paired with guided expertise for streamlining processes, in the end, makes drugs safer for patients…even before these drugs go to market.”
BioData Solutions and Ariadne Software will make their first joint appearance at the 2023 AAPS National Biotechnology Conference (NBC 2023) in Philadelphia April 23-26 (Booth 213). The NBC 2023 conference includes a panel discussion in which Dr. Pasas-Farmer will co-present thoughts about common challenges in bioanalytical cell and gene therapy assays. LEARN MORE
ABOUT BIODATA SOLUTIONS AND ARIADNE SOFTWARE
BioData Solutions LLC, the parent company of Ariadne Software, was founded in 2015 by Dr. Stephanie Pasas-Farmer, PhD. BioData Solutions specializes in bioanalytical consulting services ranging from strategic guidance to data review and analysis, and from small molecules to cell and gene therapy.
Ariadne Software, also founded by Dr. Pasas-Farmer, was established in 2018 as a pharmaceutical software development company. Ariadne specializes in software automation solutions for bioanalytical assays and is best known for its pioneering software, AI-driven Red Thread.